PDLIM4 and breast cancer: The LIM-homeodomain TFs, reversion-induced Lim (RIL) or PDZ and LIM domain 4 (PDLIM4), promote apoptosis in cancer cells and, hence, are silenced epigenetically in AML and MDS [69], as well as breast cancer [70].